CUDC-101

CUDC-101

CUDC-101 is a small-molecule inhibitor that targets histone deacetylases (HDACs), epidermal growth factor receptor tyrosine kinase (EGFR/ErbB1), and human epidermal growth factor receptor 2 tyrosine kinase (HER2/ErbB2). As a hybrid dual-acting inhibitor, it not only blocks these receptors but also reduces compensatory pathways such as AKT, HER3, and MET. CUDC-101 shows potential in suppressing various tumor progressions. Reagent grade, for research purpose.

Molecular structure of the compound BP-40066
    • Unit
    • Price
    • Qty
    • 25 MG
    • $120.00
    • 50 MG
    • $230.00
    • 100 MG
    • $430.00
    • 250 MG
    • $850.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire